ENCBS186AAA / cell line
Summary
- Status
- released
- Term name
- GM10847
- Term ID
- EFO:0005336
- Summary
- Homo sapiens GM10847 cell line treated with 25 ng/mL tumor necrosis factor for 6 hours
- Description
- B-lymphoblastoid cell line, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed; treated with TNFa
- Product ID
- GM10847
Attribution
ENCODE2 project
- Lab
- Michael Snyder, Stanford
- Award PI
- Michael Snyder, Stanford
- Submitted by
- Michael Snyder
- Source
- Coriell
- Project
- ENCODE
- External resources
Treatment details
- Treatment
- 25 ng/mL tumor necrosis factor (UniProtKB:P01375) for 6 hours
- Type
- protein
Donor information
- Status
- released
- Accession
- ENCDO000ABK
- Aliases
- encode:donor of GM10847
- Species
- Homo sapiens
- Life stage
- unknown
- Age
- Unknown
- Sex
- female
- Health status
- unknown
- Ethnicity
- European
Documents
general protocol
Description: General Protocol for GM Lymphoblastoid Cells (Coriell)
- Submitted by
- Michael Snyder
- Lab
- Michael Snyder, Stanford
- Grant
- U54HG004558
treatment protocol
Description: Cell culture TNF-alpha treatment protocol
- Submitted by
- Trupti Kawli
- Lab
- Michael Snyder, Stanford
- Grant
- U54HG004558